4//SEC Filing
Shabahang Shahrokh 4
Accession 0001213900-21-016947
CIK 0001726711other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:16 PM ET
Size
7.4 KB
Accession
0001213900-21-016947
Insider Transaction Report
Form 4
Shabahang Shahrokh
DirectorCHIEF INNOVATION OFFICER
Transactions
- Exercise Out-of-Money
Common Stock
2021-03-17$4.00/sh+18,750$75,000→ 1,015,006 total(indirect: See Footnote) - Exercise Out-of-Money
Warrant (Right to Buy)
2021-03-17−18,750→ 0 total(indirect: See Footnote)Exercise: $4.00From: 2018-03-17Exp: 2021-03-17→ Common Stock (18,750 underlying)
Footnotes (2)
- [F1]967,784 shares of common stock are owned beneficially by the Shabahang-Hatami Family Trust, Shahrokh Shabahang, Trustee.
- [F2]Held beneficially by the Shabahang-Hatami Family Trust, Shahrokh Shabahang, Trustee.
Documents
Issuer
Aditx Therapeutics, Inc.
CIK 0001726711
Entity typeother
Related Parties
1- filerCIK 0001816754
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 4:16 PM ET
- Size
- 7.4 KB